A DNA Vaccine for Ebola Virus Is Safe and Immunogenic in a Phase I Clinical Trial
Julie E. Martin(National Institutes of Health), Zoe Moodie(Fred Hutch Cancer Center), Charla Andrews(National Institutes of Health), Richard A. Koup(Aaron Diamond AIDS Research Center), Barney S. Graham(National Institutes of Health), Mary E. Enama(National Institutes of Health), Ingelise J. Gordon(National Institute of Allergy and Infectious Diseases), Gary J. Nabel(National Institutes of Health), Robert T. Bailer(National Institutes of Health), Bimal K. Chakrabarti(University of Vienna), Phillip L. Gomez(National Institutes of Health), Mario Roederer(National Institutes of Health), Michael A. Bailey(National Institutes of Health), Judith A. Stein(National Institutes of Health), Nancy J. Sullivan(National Institute of Allergy and Infectious Diseases), Lin Gu(Shanghai Public Health Clinical Center)
Cited by 236
Related Papers
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
|Science|2020|9.8k
A human memory T cell subset with stem cell–like properties
|Nature Medicine|2011|2k
Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
|Science|2010|1.8k
Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation
|Journal of Immunological Methods|2003|1.6k